ro 8-0576 has been researched along with triiodothyronine in 1 studies
| Studies (ro 8-0576) | Trials (ro 8-0576) | Recent Studies (post-2010) (ro 8-0576) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
|---|---|---|---|---|---|
| 214 | 63 | 67 | 26,247 | 861 | 3,473 |
| Protein | Taxonomy | ro 8-0576 (IC50) | triiodothyronine (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
| Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A | 1 |
1 other study(ies) available for ro 8-0576 and triiodothyronine
| Article | Year |
|---|---|
Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1982 |